ASTRAZENECA FDA Approval NDA 014763

NDA 014763

ASTRAZENECA

FDA Drug Application

Application #014763

Application Sponsors

NDA 014763ASTRAZENECA

Marketing Status

Discontinued003
Discontinued004
Discontinued005
Discontinued007
Discontinued008

Application Products

003INJECTABLE;INJECTION3% **Federal Register determination that product was not discontinued or withdrawn for safety or efficacy reasons**1CITANESTPRILOCAINE HYDROCHLORIDE
004INJECTABLE;INJECTION1% **Federal Register determination that product was not discontinued or withdrawn for safety or efficacy reasons**1CITANESTPRILOCAINE HYDROCHLORIDE
005INJECTABLE;INJECTION2% **Federal Register determination that product was not discontinued or withdrawn for safety or efficacy reasons**1CITANESTPRILOCAINE HYDROCHLORIDE
007INJECTABLE;INJECTION4% **Federal Register determination that product was not discontinued or withdrawn for safety or efficacy reasons**1CITANEST PLAINPRILOCAINE HYDROCHLORIDE
008INJECTABLE;INJECTION0.005MG/ML;4%0CITANEST FORTEEPINEPHRINE BITARTRATE; PRILOCAINE HYDROCHLORIDE

FDA Submissions

TYPE 1; Type 1 - New Molecular EntityORIG1AP1965-11-18PRIORITY
MANUF (CMC); Manufacturing (CMC)SUPPL10AP1976-03-03PRIORITY
LABELING; LabelingSUPPL11AP1976-03-03PRIORITY
MANUF (CMC); Manufacturing (CMC)SUPPL13AP1979-04-09PRIORITY
LABELING; LabelingSUPPL14AP1979-04-04PRIORITY
LABELING; LabelingSUPPL15AP1979-08-29PRIORITY
MANUF (CMC); Manufacturing (CMC)SUPPL16AP1981-05-08PRIORITY
MANUF (CMC); Manufacturing (CMC)SUPPL17AP1981-08-31PRIORITY
MANUF (CMC); Manufacturing (CMC)SUPPL18AP1982-07-27PRIORITY
LABELING; LabelingSUPPL19AP1982-07-27PRIORITY
LABELING; LabelingSUPPL20AP1981-08-31PRIORITY
LABELING; LabelingSUPPL21AP1985-03-24PRIORITY
LABELING; LabelingSUPPL22AP1985-03-22PRIORITY
MANUF (CMC); Manufacturing (CMC)SUPPL23AP1982-06-28PRIORITY
LABELING; LabelingSUPPL24AP1986-08-29PRIORITY
LABELING; LabelingSUPPL25AP1986-03-21PRIORITY
LABELING; LabelingSUPPL26AP1987-03-11PRIORITY
LABELING; LabelingSUPPL34AP1997-05-09PRIORITY
MANUF (CMC); Manufacturing (CMC)SUPPL35AP1996-05-31PRIORITY
MANUF (CMC); Manufacturing (CMC)SUPPL36AP2000-12-01PRIORITY

Submissions Property Types

ORIG1Null0
SUPPL10Null0
SUPPL11Null0
SUPPL13Null0
SUPPL14Null0
SUPPL15Null0
SUPPL16Null0
SUPPL17Null0
SUPPL18Null0
SUPPL19Null0
SUPPL20Null0
SUPPL21Null0
SUPPL22Null0
SUPPL23Null0
SUPPL24Null0
SUPPL25Null0
SUPPL26Null0
SUPPL34Null0
SUPPL35Null0
SUPPL36Null0

CDER Filings

ASTRAZENECA
cder:Array
(
    [0] => Array
        (
            [ApplNo] => 14763
            [companyName] => ASTRAZENECA
            [docInserts] => ["",""]
            [products] => [{"drugName":"CITANEST","activeIngredients":"PRILOCAINE HYDROCHLORIDE","strength":"3% **Federal Register determination that product was not discontinued or withdrawn for safety or efficacy reasons**","dosageForm":"INJECTABLE;INJECTION","marketingStatus":"Discontinued","te":"None","rld":"Yes","rs":"No"},{"drugName":"CITANEST","activeIngredients":"PRILOCAINE HYDROCHLORIDE","strength":"1% **Federal Register determination that product was not discontinued or withdrawn for safety or efficacy reasons**","dosageForm":"INJECTABLE;INJECTION","marketingStatus":"Discontinued","te":"None","rld":"Yes","rs":"No"},{"drugName":"CITANEST","activeIngredients":"PRILOCAINE HYDROCHLORIDE","strength":"2% **Federal Register determination that product was not discontinued or withdrawn for safety or efficacy reasons**","dosageForm":"INJECTABLE;INJECTION","marketingStatus":"Discontinued","te":"None","rld":"Yes","rs":"No"},{"drugName":"CITANEST FORTE","activeIngredients":"EPINEPHRINE BITARTRATE; PRILOCAINE HYDROCHLORIDE","strength":"0.005MG\/ML;4%","dosageForm":"INJECTABLE;INJECTION","marketingStatus":"Discontinued","te":"None","rld":"No","rs":"No"},{"drugName":"CITANEST PLAIN","activeIngredients":"PRILOCAINE HYDROCHLORIDE","strength":"4% **Federal Register determination that product was not discontinued or withdrawn for safety or efficacy reasons**","dosageForm":"INJECTABLE;INJECTION","marketingStatus":"Discontinued","te":"None","rld":"Yes","rs":"No"}]
            [labels] => 
            [originalApprovals] => [{"actionDate":"CITANEST","submission":"PRILOCAINE HYDROCHLORIDE","actionType":"3% **Federal Register determination that product was not discontinued or withdrawn for safety or efficacy reasons**","submissionClassification":"INJECTABLE;INJECTION","reviewPriority":"Discontinued","inserts":"[]","notes":">Yes"},{"actionDate":"CITANEST","submission":"PRILOCAINE HYDROCHLORIDE","actionType":"1% **Federal Register determination that product was not discontinued or withdrawn for safety or efficacy reasons**","submissionClassification":"INJECTABLE;INJECTION","reviewPriority":"Discontinued","inserts":"[]","notes":">Yes"},{"actionDate":"CITANEST","submission":"PRILOCAINE HYDROCHLORIDE","actionType":"2% **Federal Register determination that product was not discontinued or withdrawn for safety or efficacy reasons**","submissionClassification":"INJECTABLE;INJECTION","reviewPriority":"Discontinued","inserts":"[]","notes":">Yes"},{"actionDate":"CITANEST FORTE","submission":"EPINEPHRINE BITARTRATE; PRILOCAINE HYDROCHLORIDE","actionType":"0.005MG\/ML;4%","submissionClassification":"INJECTABLE;INJECTION","reviewPriority":"Discontinued","inserts":"[]","notes":">No"},{"actionDate":"CITANEST PLAIN","submission":"PRILOCAINE HYDROCHLORIDE","actionType":"4% **Federal Register determination that product was not discontinued or withdrawn for safety or efficacy reasons**","submissionClassification":"INJECTABLE;INJECTION","reviewPriority":"Discontinued","inserts":"[]","notes":">Yes"}]
            [supplements] => 
            [actionDate] => 1969-12-31
        )

)

© 2024 FDA.report
This site is not affiliated with or endorsed by the FDA.